NSE: SAILIFE · 2 November 2026
- Sai Life Sciences Ltd. (SAILIFE) declined 0.98% on 02-Nov-2026, closing at ₹1,542.30 compared to its previous close of ₹1,557.50.
- a press release dated August 06, 2026, titled "Press release for the Un-audited Financial Results for the quarter ended on 30 June 2026".
- Trading volume was 1.32 times the 20-day average daily volume.
Why is Sai Life Sciences share price falling on 2 November 2026?
Sai Life Sciences Ltd. (SAILIFE) declined 0.98% on 02-Nov-2026, closing at ₹1,542.30 compared to its previous close of ₹1,557.50.
While the broader Nifty index advanced 1.68% during the session, the Nifty Pharma sector benchmark remained relatively flat with a minor dip of 0.07%, reflecting subdued momentum across pharmaceutical names. Sai Life Sciences underperformed both the broader market and its sector benchmark for the day, though this move follows a strong recent run that included a 5-day return of 6.71% and a prior session gain of 4.13%.
Company disclosures from October highlight operational and investor engagement updates, including the scheduling of an analyst and investor meet on 19-Oct-2026 to discuss financial results for the quarter and half-year ended 30-Sep-2026. However, no immediate fresh operational catalysts or corporate announcements were published on 02-Nov-2026 to directly explain today's pullback. The modest correction appears consistent with routine profit-taking following its recent multi-day gains rather than any adverse company-specific development.
6.31 lakh shares traded by 2 November 2026 · 03:30 PM IST. This compares with a 20-day average daily volume of 4.78 lakh shares (1.32 times). The five-day average daily volume was 4.86 lakh shares. Separately, the NSE report for 2 November 2026 showed 3.52 lakh shares delivered, representing 55.75% of that day’s traded volume. The same report recorded 53,619 trades.
The stock declined by 0.98% on above-average volume following a strong multi-day advance, including a 4.13% gain in the prior session and a 6.71% return over five trading days. In the absence of negative same-day news, the pullback points toward standard profit-taking.
Latest Company Developments
a press release dated August 06, 2026, titled "Press release for the Un-audited Financial Results for the quarter ended on 30 June 2026".
Ownership & Transaction Activity
Mutual Fund Holdings
Mutual funds held 29.56% on 30 September 2026. This compares with 29.47% on 30 June 2026, a change of +0.09 percentage points.
The filing reported 31 MF/UTI holders.
Research & Brokerage Views
Maintained a positive stance on Sai Life Sciences with a target price of ₹1620, supported by the company's strong positioning as an integrated CRDMO.
Identified Sai Life Sciences as a top CRDMO pick, outlining multiple structural growth drivers across discovery and manufacturing segments.
What to Watch Next
- Upcoming financial results and operational updates for the quarter ended 30th September 2026
- Delivery participation trends relative to the 20-day average volume of 631,369 shares
- Execution of growth initiatives across global research and manufacturing facilities
- Sector performance relative to the Nifty Pharma benchmark
More Sai Life Sciences news and dated analysis →
Frequently Asked Questions
What is the latest Sai Life Sciences company news?
a press release dated August 06, 2026, titled "Press release for the Un-audited Financial Results for the quarter ended on 30 June 2026".
How strong was Sai Life Sciences’s trading volume?
6.31 lakh shares traded, 1.32 times the 20-day average daily volume. The price and volume data are dated 2 November 2026 · 03:30 PM IST.
Do the mutual-fund figures show buying today?
They show holdings on 30 September 2026. Quarterly holdings do not identify purchases made on the article date.
Research & analysis: WittyTrades Research Desk
Reviewed by: Mohanish Sanghavi — SEBI Registered Research Analyst
Disclaimer: Investments in securities markets are subject to market risks. Registration with SEBI and NISM certification do not guarantee performance or returns. This article is for information and education, not personalised investment advice or a recommendation to buy, sell or hold.